Implementation of a HABIT-ILE Intervention at William Lennox Neurological Hospital (NeuREHA)
NCT ID: NCT05900778
Last Updated: 2023-06-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
40 participants
INTERVENTIONAL
2023-06-10
2028-06-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Implementation of a HABIT-ILE Intervention at William Lennox Neurological Hospital (NeuREHA) - Adult
NCT06931795
HABIT-ILE in Adults With Chronic Stroke (HABIT-ILE Stroke)
NCT04664673
Implementation of a HABIT-ILE Intervention at Home for Chronic Stroke
NCT05727111
Pilot Study Concerning an Intelligent Activity-based Client-centred Training System in Neurorehabilitation
NCT04692311
Exploring Motor Learning in Acute Stroke Through Robotics
NCT04171856
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The hypothesis is that an in-hospital HABIT-ILE protocol will be more effective than conventional therapies usually given to children with acquired brain injury, and that this difference will be objectively demonstrated by clinical assessments of motor function, cognition and participation conducted before and after treatment periods.
The aim of the study is therefore to evaluate the effect of intensive bimanual hand-arm therapy including the lower extremities (HABIT-ILE) on body functions and structures, activity and participation in children with acquired brain injury.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HABIT-ILE
Hand and arm bimanuel intensive therapy including lowers extremities
HABIT-ILE
2 weeks HABIT-ILE
Conventional intervention
Conventional physical and occupational therapy
Conventional intervention
2 weeks usual intervention (waitlist group)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
HABIT-ILE
2 weeks HABIT-ILE
Conventional intervention
2 weeks usual intervention (waitlist group)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age 5 to 18 years inclusive
Exclusion Criteria
* programmed botulinum toxin or orthopedic surgery in the 6 months previous to the intervention, during intervention period or 3months after the intervention time
* Severe visual or cognitive impairments likely to interfere with intervention or testing session completion
5 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Université Catholique de Louvain
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yannick Bleyenheuft
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yannick Bleyenheuft, Professor
Role: PRINCIPAL_INVESTIGATOR
Insititue of Neurosciences, UCLouvain
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier Neurologique William Lennox
Ottignies-Louvain-la-Neuve, Brabant-Wallon, Belgium
Institute of Neurosciences, UCLouvain
Brussels, , Belgium
Spontaneous contact via doctors or other partners
Brussels, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B0392023000044
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.